Lifebit
Share
Curing diseases by empowering data custodians to make their biomedical data findable and usable.
Lifebit is a global leader in multi-omics and health data software, empowering organisations across the globe to transform how they securely and safely leverage sensitive biomedical data. We are committed to solving the most challenging problems in precision medicine, genomics and healthcare with a mission to create a world where access to biomedical data will never again be an obstacle to curing diseases.
29/02/2024
Discover the most exciting and innovative approaches for precision medicine this year with our white paper, featuring insights on five key trends:
👩💻 Leveraging innovative technology for secure data linkage and access
💊 Utilising diverse data in clinical trials for drug discovery
👶 Implementing genomic sequencing for newborns
🤝 Involving the public to earn and strengthen trust
🌍 Fostering global collaboration among biobanks, pharmaceutical companies, and healthcare providers
Join the conversation by downloading our white paper, sharing your thoughts using and look out for our polls this week: https://bit.ly/3uRcClt
29/02/2024
🌟 Today, on Rare Disease Day, we're honoured to stand alongside our Client Manager, Charlotte Maughan, and others impacted by rare diseases.
Charlotte's powerful words remind us of the importance of raising awareness and advocating for those whose conditions often go unnoticed or misunderstood.
Charlotte's first hand experience sheds light on the challenges faced by individuals living with a rare disease in securing a diagnosis, especially when dealing with "invisible diseases" that lack clear physical symptoms.
At Lifebit, we're committed to supporting individuals like Charlotte by providing innovative solutions to our clients to help facilitate research, diagnosis and, ultimately, improved treatment options for rare diseases.
Together, let's continue to amplify the voices of those affected by rare conditions and work towards a future where no one's struggle goes unnoticed.
29/02/2024
🌟 Today, on Rare Disease Day, we're honoured to stand alongside our Client Manager, Charlotte Maughan, and others impacted by rare diseases.
Charlotte's powerful words remind us of the importance of raising awareness and advocating for those whose conditions often go unnoticed or misunderstood.
Charlotte's first hand experience sheds light on the challenges faced by individuals living with a rare disease in securing a diagnosis, especially when dealing with "invisible diseases" that lack clear physical symptoms.
At Lifebit, we're committed to supporting individuals like Charlotte by providing innovative solutions to facilitate research, diagnosis and, ultimately, improved treatment options for rare diseases. Together, let's continue to amplify the voices of those affected by rare conditions and work towards a future where no one's struggle goes unnoticed.
28/02/2024
🔍 Learn about the critical components of high-quality patient registries and learn how FAIR (Findable, Accessible, Interoperable, Reusable) principles are facilitating healthcare data management in our latest blog, exploring:
-Key requirements for establishing high-quality patient registries.
-The transformative role of FAIR principles in data governance.
-Practical applications of FAIR principles in healthcare.
Read more here: https://bit.ly/48AqnCQ
27/02/2024
We are thrilled to share our news story about our CEO, Dr. Maria Dunford, accompanying the Greek Prime Minister, Mr. Kyriakos Mitsotakis on a significant trade visit to India! 🇬🇷🇮🇳
Facilitated by EnterpriseGreece and the Ministry of Foreign Affairs, this mission aims to strengthen strategic partnerships between Greece and India in technology and pharmaceuticals, focusing on advancing precision medicine and biotech ecosystems.
Maria, one of 10 Greek tech entrepreneurs selected for this delegation, expressed her enthusiasm for representing the European tech sector and discussing opportunities to bring precision medicine to life in India. 🚀
Read the full story here: https://bit.ly/49uLRm2
Exciting news about our global data network at Lifebit 🎉
Enabled through our fantastic global partnerships, Lifebit has reached a significant milestone by curating a multi-omic and health data catalog encompassing over 100 million patients worldwide.
Aimed at pharma companies requiring deep, diverse data at scale to speed up drug development and clinical trials, Lifebit’s data catalog is pivotal for advancing precision medicine.
The comprehensive data covers over 200 health conditions, including critical disease areas like cancer, cardiovascular, respiratory, neurological, diabetes, and rare diseases.
This milestone aligns with the recent launch of Lifebit's Platform 2.0, an advanced federated research environment designed to maximize research discoveries while ensuring data privacy and security.
For more details about our extensive data catalog: https://bit.ly/4306YKv
22/02/2024
🚀 Breaking news! Lifebit expands into APJ with a new HQ in Singapore, partnering with Synapxe to advance precision medicine. 🧬
Lifebit's CEO Maria Chatzou Dunford expressed:
"We are delighted to be expanding our operations with a new regional headquarters in Singapore. Our presence here presents a unique opportunity to support the diverse data needs of healthcare organisations, research institutes and pharma companies in the region."
Chief Data Officer and Director, Data Analytics & AI of Synapxe, Andy Ta said:
"Through our collaboration, we aim to accelerate clinico-genomic data for precision medicine."
Read more about this milestone and its significance in improving public outcomes in the region through precision medicine research: https://bit.ly/3OQtks5
21/02/2024
💡Discover the game-changing role of patient registries in healthcare!
Our latest blog unveils the transformative impact of these tools, shedding light on their vital role in rare disease research. From overcoming data limitations to fostering collaboration, patient registries are changing how we understand and treat rare conditions.
🧬📊 Uncover the innovative ways patient registries are shaping the future of healthcare in our insightful blog post: https://bit.ly/49H6cnN
At Lifebit, we develop secure federated data analysis solutions for clients to help researchers turn data into discoveries. Get in touch and book a demo: https://bit.ly/3OPNIJQ
🔬🧬 Dive into the world of genomics with Serena Nik-Zainal from the University of Cambridge at the event that took place in December. Discover how genomic information can revolutionise healthcare by predicting treatment outcomes and drug sensitivity.
Serena explores the critical role of treatment and outcome data in patient care, showcasing how NHS England's DigiTrials and Genomics England accelerate this process in the UK. Take advantage of this insightful discussion!
Watch on demand: https://bit.ly/48l2dfz
Explore our newest blog post! Learn how our collaboration with Genomics England, chosen by Health Data Research UK (HDR UK) and EHDEN, is shaping the future of healthcare research. Together, we're standardising data from 135,000+ participants, accelerating scientific discoveries in cancer, rare diseases, and COVID-19.
Jonathan Blanksby, Product Manager at Genomics England, said:
“The mappings that are being shared today are a great step in the right direction for standardising the great breadth of data that Genomics England has in its Research Environment.”
Read more:
🌟 Dive deeper into the future of precision medicine with our on-demand videos from !
Anne Deslattes Mays, joined by other industry leaders, emphasised the critical need for collaboration and empowerment in tackling healthcare challenges.
Chaired by Chris Tunnell, Lifebit's SVP of Sales, the panel featured insights from Paul Agapow, Director of Statistics at , Dr. Thomas Kandl, Healthcare Data Officer at Ingelheim and Dr. David Kavanagh, VP and Managing Director at Genuity Science.
Paul underscored the importance of holistic data analysis, advocating for multimodal approaches. Thomas stressed precision in drug discovery, highlighting the significance of well-framed queries. Anne discussed the evolving landscape of genomic research, emphasising the need for continuous learning. David shared Genuity Science's journey, emphasising the value of exploring diverse datasets for comprehensive insights.
Watch on demand: https://bit.ly/3I3XqVf
🔬✨ Last Friday, we proudly joined the global celebration of International Day of Women and Girls in Science, recognising the pivotal contributions of women in STEM.
We had the privilege of sitting down with Hadley Sheppard, PhD, Ilona Carneiro, Hannah Gaimster and Anya Iesenfeld, who shared their inspiring journeys in science and technology.
We hope their insights inspire and serve as guiding lights for aspiring women and girls in STEM. Together, let's foster inclusivity, empower diversity and build a future where every woman and girl has the opportunity to thrive in STEM.
If you haven't already, read the full blog here: https://bit.ly/49bNdSl
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
28-29 Threadneedle Str, 4th Floor
London
EC2R8AY